Clinuvel Pharmaceuticals (CLVLY)

[sante1]

https://www.sharewise.com/de/ratings/561738

In Germany they expect an SP of €10,00 next year februari!
For now th SP of CUV went up $0,14, closing price $5,29, volume more then 56.000!

CLVLY at the moment$3,97. A plus of $0,02.
Is this coincidence US $3,97 = AUS $ 5,29!
Is this coincidence or manipulation?
I personaly don't believe in coincidence!

$4,04 closing price, day high?

Clinuvel one of the low risks shares at the very moment.

Upward momentum more then 190%!



From sharescene (CUV)

short term milestones :

Sept: start of German distribution
Oct: FDA meeting outcome EPP with a better view on start of US distribution in 2017, short track status and I hope even early access
Oct: Quarterly report with hopefully positive eps level and distribution in Netherlands, Italy, Switzerland, Austria and Germany
Nov: vitiligo full results from Singapore phase II study
Nov: FDA meeting news on the vitiligo program endorsement and path to market
Dec: start of distribution in other EU countries Belgium, Denmark, Norway, France and maybe UK
Dec: Vallaurix progress on the development of non-prescriptive formulations to be administered topically as adjuvant maintenance vitiligo treatment. (as you can read on page 9 of the preliminary final report)


Revenue is the strongest PR you can have. What jolted me into picking up 11k more shares this past week (avg price 3.9) was the realization that:

Overall Market Volume Naturally Increases in September
...coupled with the fact that we know with certainty our numbers will double from last year for the third quarter and we're going to be CASH FLOW POSITIVE
EPP is on the fasttrack to approval, very few drugs get turned down at this stage if memory serves
There's nothing stopping Vitiligo patients from getting Scenesse after it's approved for EPP (or so it appears.) Now I realize why my Doctor was so positive about Scenesse being available for Vitiligo
I'm going to need to make a shitload off of this stock to pay for the damn Scenesse!!!
The OTC/cream versions are going forward.
We're on a clear path to the NASDAQ